Bone metabolism in pediatric burned patients

A review

Eric Schryver, Gordon L. Klein, David Herndon, Oscar Suman, Ludwik Branski, Linda Sousse

Research output: Contribution to journalArticle

Abstract

Severe burns in children can lead to growth delays, bone loss, and wasting of lean body mass and muscle with subsequent long-term effects such as osteoporosis. The following review examines 11 randomized, placebo-controlled, prospective clinical trials in pediatric burns between 1995 and 2017. These studies included approximately 250 burned children, and they were conducted to evaluate the impact of severe burn on markers of bone formation and bone metabolism. Some trials also analyzed current therapy regimens such as pamidronate and vitamin D. The clinical utility of these outlined biomarkers is uncertain with regard to acute burn care, as the current literature remains unclear. This review thus serves to address the impact of severe burn on markers of bone formation and bone metabolism in pediatric patients but will not focus on the clinical utility of the markers. The aim of this review is to summarize the findings of the trials to guide the future care of burned patients to maximize bone recovery.

Original languageEnglish (US)
JournalBurns
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

pamidronate
Pediatrics
Burns
Osteogenesis
Bone and Bones
Biomarkers
Bone Development
Controlled Clinical Trials
Vitamin D
Osteoporosis
Patient Care
Placebos
Muscles
Therapeutics

Keywords

  • Aluminum
  • Bone metabolism
  • Bone morphogenetic protein-2
  • Burns
  • Calcium
  • Osteocalcin
  • Parathyroid hormone
  • Sclerostin
  • Type I collagen
  • Urine free cortisol
  • Vitamin D
  • Vitamin D

ASJC Scopus subject areas

  • Surgery
  • Emergency Medicine
  • Critical Care and Intensive Care Medicine

Cite this

Bone metabolism in pediatric burned patients : A review. / Schryver, Eric; Klein, Gordon L.; Herndon, David; Suman, Oscar; Branski, Ludwik; Sousse, Linda.

In: Burns, 01.01.2018.

Research output: Contribution to journalArticle

@article{942e5f5b30ac403681573120982580d5,
title = "Bone metabolism in pediatric burned patients: A review",
abstract = "Severe burns in children can lead to growth delays, bone loss, and wasting of lean body mass and muscle with subsequent long-term effects such as osteoporosis. The following review examines 11 randomized, placebo-controlled, prospective clinical trials in pediatric burns between 1995 and 2017. These studies included approximately 250 burned children, and they were conducted to evaluate the impact of severe burn on markers of bone formation and bone metabolism. Some trials also analyzed current therapy regimens such as pamidronate and vitamin D. The clinical utility of these outlined biomarkers is uncertain with regard to acute burn care, as the current literature remains unclear. This review thus serves to address the impact of severe burn on markers of bone formation and bone metabolism in pediatric patients but will not focus on the clinical utility of the markers. The aim of this review is to summarize the findings of the trials to guide the future care of burned patients to maximize bone recovery.",
keywords = "Aluminum, Bone metabolism, Bone morphogenetic protein-2, Burns, Calcium, Osteocalcin, Parathyroid hormone, Sclerostin, Type I collagen, Urine free cortisol, Vitamin D, Vitamin D",
author = "Eric Schryver and Klein, {Gordon L.} and David Herndon and Oscar Suman and Ludwik Branski and Linda Sousse",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.burns.2018.04.014",
language = "English (US)",
journal = "Burns",
issn = "0305-4179",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Bone metabolism in pediatric burned patients

T2 - A review

AU - Schryver, Eric

AU - Klein, Gordon L.

AU - Herndon, David

AU - Suman, Oscar

AU - Branski, Ludwik

AU - Sousse, Linda

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Severe burns in children can lead to growth delays, bone loss, and wasting of lean body mass and muscle with subsequent long-term effects such as osteoporosis. The following review examines 11 randomized, placebo-controlled, prospective clinical trials in pediatric burns between 1995 and 2017. These studies included approximately 250 burned children, and they were conducted to evaluate the impact of severe burn on markers of bone formation and bone metabolism. Some trials also analyzed current therapy regimens such as pamidronate and vitamin D. The clinical utility of these outlined biomarkers is uncertain with regard to acute burn care, as the current literature remains unclear. This review thus serves to address the impact of severe burn on markers of bone formation and bone metabolism in pediatric patients but will not focus on the clinical utility of the markers. The aim of this review is to summarize the findings of the trials to guide the future care of burned patients to maximize bone recovery.

AB - Severe burns in children can lead to growth delays, bone loss, and wasting of lean body mass and muscle with subsequent long-term effects such as osteoporosis. The following review examines 11 randomized, placebo-controlled, prospective clinical trials in pediatric burns between 1995 and 2017. These studies included approximately 250 burned children, and they were conducted to evaluate the impact of severe burn on markers of bone formation and bone metabolism. Some trials also analyzed current therapy regimens such as pamidronate and vitamin D. The clinical utility of these outlined biomarkers is uncertain with regard to acute burn care, as the current literature remains unclear. This review thus serves to address the impact of severe burn on markers of bone formation and bone metabolism in pediatric patients but will not focus on the clinical utility of the markers. The aim of this review is to summarize the findings of the trials to guide the future care of burned patients to maximize bone recovery.

KW - Aluminum

KW - Bone metabolism

KW - Bone morphogenetic protein-2

KW - Burns

KW - Calcium

KW - Osteocalcin

KW - Parathyroid hormone

KW - Sclerostin

KW - Type I collagen

KW - Urine free cortisol

KW - Vitamin D

KW - Vitamin D

UR - http://www.scopus.com/inward/record.url?scp=85050813587&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85050813587&partnerID=8YFLogxK

U2 - 10.1016/j.burns.2018.04.014

DO - 10.1016/j.burns.2018.04.014

M3 - Article

JO - Burns

JF - Burns

SN - 0305-4179

ER -